Ameriprise
NUVA

Ameriprise’s NuVasive, Inc. NUVA Stock Holding History

Ameriprise’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-242,806
Closed -$10.1M – 4010
2023
Q2 		$10.1M Sell
242,806
-12,130
-5% -$498K ﹤0.01% 1761
2023
Q1 		$10.5M Sell
254,936
-67,746
-21% -$2.9M ﹤0.01% 1731
2022
Q4 		$13.3M Buy
322,682
+171,427
+113% +$6.94M ﹤0.01% 1506
2022
Q3 		$6.63M Sell
151,255
-40,537
-21% -$1.96M ﹤0.01% 2022
2022
Q2 		$9.43M Sell
191,792
-3,267
-2% -$175K ﹤0.01% 1796
2022
Q1 		$11.1M Sell
195,059
-22,245
-10% -$1.18M ﹤0.01% 1839
2021
Q4 		$11.4M Sell
217,304
-17,994
-8% -$978K ﹤0.01% 1883
2021
Q3 		$14.1M Sell
235,298
-18,367
-7% -$1.13M ﹤0.01% 1565
2021
Q2 		$17.2M Buy
253,665
+44,352
+21% +$3.03M 0.01% 1470
2021
Q1 		$13.7M Buy
209,313
+17,755
+9% +$1.07M ﹤0.01% 1620
2020
Q4 		$10.8M Buy
191,558
+24,892
+15% +$1.22M ﹤0.01% 1700
2020
Q3 		$8.09M Sell
166,666
-3,442
-2% -$185K ﹤0.01% 1708
2020
Q2 		$9.47M Sell
170,108
-33,863
-17% -$1.96M ﹤0.01% 1571
2020
Q1 		$10.4M Buy
203,971
+12,716
+7% +$853K 0.01% 1364
2019
Q4 		$14.8M Sell
191,255
-12,162
-6% -$859K 0.01% 1410
2019
Q3 		$12.9M Buy
203,417
+8,089
+4% +$506K 0.01% 1491
2019
Q2 		$11.4M Sell
195,328
-4,625
-2% -$273K 0.01% 1617
2019
Q1 		$11.4M Sell
199,953
-23,866
-11% -$1.27M 0.01% 1593
2018
Q4 		$11.1M Sell
223,819
-4,009
-2% -$241K 0.01% 1516
2018
Q3 		$16.2M Buy
227,828
+6,113
+3% +$389K 0.01% 1469
2018
Q2 		$11.6M Buy
221,715
+43,567
+24% +$2.28M 0.01% 1623
2018
Q1 		$9.3M Buy
178,148
+8,544
+5% +$433K ﹤0.01% 1725
2017
Q4 		$9.92M Buy
169,604
+24,883
+17% +$1.41M ﹤0.01% 1616
2017
Q3 		$8.03M Sell
144,721
-795
-0.5% -$52.6K ﹤0.01% 1751
2017
Q2 		$11.2M Buy
145,516
+6,880
+5% +$514K 0.01% 1455
2017
Q1 		$10.4M Sell
138,636
-39,015
-22% -$2.83M 0.01% 1489
2016
Q4 		$12M Sell
177,651
-115,572
-39% -$7.45M 0.01% 1384
2016
Q3 		$19.5M Sell
293,223
-81,271
-22% -$5.18M 0.01% 956
2016
Q2 		$22.4M Buy
374,494
+140,894
+60% +$7.62M 0.01% 844
2016
Q1 		$11.4M Buy
233,600
+3,568
+2% +$162K 0.01% 1323
2015
Q4 		$12.4M Sell
230,032
-1,046
-0.5% -$53.3K 0.01% 1278
2015
Q3 		$11.1M Buy
231,078
+2,354
+1% +$122K 0.01% 1381
2015
Q2 		$10.8M Buy
228,724
+5,410
+2% +$253K 0.01% 1527
2015
Q1 		$10.3M Sell
223,314
-8,664
-4% -$403K 0.01% 1534
2014
Q4 		$10.9M Buy
231,978
+26,733
+13% +$1.11M 0.01% 1433
2014
Q3 		$7.16M Buy
205,245
+9,449
+5% +$336K ﹤0.01% 1748
2014
Q2 		$6.96M Buy
195,796
+10,255
+6% +$351K ﹤0.01% 1827
2014
Q1 		$7.13M Buy
185,541
+9,002
+5% +$331K ﹤0.01% 1792
2013
Q4 		$5.71M Buy
176,539
+5,866
+3% +$176K ﹤0.01% 1923
2013
Q3 		$4.18M Buy
170,673
+6,120
+4% +$151K ﹤0.01% 2055
2013
Q2 		$4.08M Buy
+164,553
New +$3.6M ﹤0.01% 2001

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ameriprise's NUVA Position: Q3 2023 in Review

Ameriprise sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 242,806 shares — an estimated $10.1M sold.

Ameriprise first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $22.4M in Q2 2016. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Ameriprise reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Ameriprise sold 242,806 NuVasive, Inc. shares in Q3 2023, an estimated $10.1M.
  • Ameriprise first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Ameriprise's NuVasive, Inc. position peaked at $22.4M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.